Literature DB >> 2108092

New mouse models for chronic Cryptosporidium infection in immunodeficient hosts.

B L Ungar1, J A Burris, C A Quinn, F D Finkelman.   

Abstract

Cryptosporidium sp. causes fulminant diarrhea and chronic infection in immunocompromised, particularly human immunodeficiency virus-infected, persons. The lack of in vitro cultivation and a suitable animal model has limited development of effective treatment. We describe two new mouse models of chronic symptomatic cryptosporidiosis in adult athymic mice and in T-cell subset-depleted mice. A progressive infection, fatal within 4 months, occurred in most adult athymic mice; a few developed stable infections. Symptoms included dehydration, weight loss, intermittent diarrhea, and jaundice. Pathologic abnormalities and organisms localized in the intestine in stable infections but involved the hepatobiliary tree and pancreas in others. Lymphoid cells from histocompatible, Cryptosporidium sp.-immune mice cured infected nude mice. Identical infections occurred in neonatally infected BALB/c mice treated with anti-CD4 monoclonal antibodies alone or also with anti-CD8 monoclonal antibodies; the mice were cured when the monoclonal antibody treatments were stopped. These models will be useful in definition of the immune defects that permit chronic cryptosporidiosis to develop and in assessment of treatment modalities.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2108092      PMCID: PMC258568          DOI: 10.1128/iai.58.4.961-969.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  The role of L3T4+ and Lyt-2+ T cells in the IgE response and immunity to Nippostrongylus brasiliensis.

Authors:  I M Katona; J F Urban; F D Finkelman
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

2.  Cryptosporidiosis in patients with AIDS.

Authors:  T R Navin; A M Hardy
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 5.226

3.  IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.

Authors:  M Sarmiento; A L Glasebrook; F W Fitch
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

4.  Evidence implicating L3T4 in class II MHC antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines.

Authors:  D B Wilde; P Marrack; J Kappler; D P Dialynas; F W Fitch
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

5.  Experimental cryptosporidiosis in laboratory mice.

Authors:  D Sherwood; K W Angus; D R Snodgrass; S Tzipori
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

6.  Complete development of Cryptosporidium in cell culture.

Authors:  W L Current; T B Haynes
Journal:  Science       Date:  1984-05-11       Impact factor: 47.728

7.  Development of human and calf Cryptosporidium in chicken embryos.

Authors:  W L Current; P L Long
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

8.  Persistent Cryptosporidium infection in congenitally athymic (nude) mice.

Authors:  J Heine; H W Moon; D B Woodmansee
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

9.  Enzyme immunoassay detection of immunoglobulin M and G antibodies to Cryptosporidium in immunocompetent and immunocompromised persons.

Authors:  B L Ungar; R Soave; R Fayer; T E Nash
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

10.  IgD-secreting murine plasmacytomas: identification and partial characterization of two IgD myeloma proteins.

Authors:  F D Finkelman; S W Kessler; J F Mushinski; M Potter
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

View more
  41 in total

1.  Immunity to Cryptosporidium muris infection in mice is expressed through gut CD4+ intraepithelial lymphocytes.

Authors:  V McDonald; H A Robinson; J P Kelly; G J Bancroft
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  CD4+ T cells are not essential for control of early acute Cryptosporidium parvum infection in neonatal mice.

Authors:  Daniel S Korbel; Farah M Barakat; James P Di Santo; Vincent McDonald
Journal:  Infect Immun       Date:  2011-01-31       Impact factor: 3.441

Review 3.  Intestinal immune response to human Cryptosporidium sp. infection.

Authors:  Birte Pantenburg; Sara M Dann; Heuy-Ching Wang; Prema Robinson; Alejandro Castellanos-Gonzalez; Dorothy E Lewis; A Clinton White
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

4.  Susceptibility of mast cell-deficient W/Wv mice to Cryptosporidium parvum.

Authors:  J A Harp; H W Moon
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

5.  Monoclonal antibody immunotherapy in nude mice persistently infected with Cryptosporidium parvum.

Authors:  J M Bjorneby; B D Hunsaker; M W Riggs; L E Perryman
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

6.  Human CD8(+) T cells clear Cryptosporidium parvum from infected intestinal epithelial cells.

Authors:  Birte Pantenburg; Alejandro Castellanos-Gonzalez; Sara M Dann; Rhykka L Connelly; Dorothy E Lewis; Honorine D Ward; A Clinton White
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

7.  Immunological response to Cryptosporidium species.

Authors:  M F Heyworth
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

8.  Putative anticryptosporidial agents tested with an immunodeficient mouse model.

Authors:  G J Leitch; Q He
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

Review 9.  The genetics of complex cholestatic disorders.

Authors:  Gideon M Hirschfield; Roger W Chapman; Tom H Karlsen; Frank Lammert; Konstantinos N Lazaridis; Andrew L Mason
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

10.  Experimental Cryptosporidium parvum infections in immunosuppressed adult mice.

Authors:  K R Rasmussen; M C Healey
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.